Evaluation of the safety profile of COVID-19 vaccines: a rapid review
Research Article
[키워드] accounted
adverse event
age
article
candidate vaccine
Candidates
clinical trial
clinical trials
COVID-19
COVID-19 vaccine
COVID-19 vaccines
DNA vaccine
eligible
Evidence
fatigue
follow-up time
Frequency
group
headache
heterogeneity
Human
Inactivated vaccine
incidence
indicate
Injection-site pain
lack
Local
Meta-analysis
Novel coronavirus diseases 2019
observational study
outcome
platform
PMC
pooled rate
proportion
protein subunit vaccine
rapid process
Reactions
recipient
Regulatory
Reporting
Research
Result
review
RNA vaccine
safety profile
searched
Serious Adverse Event
severe acute respiratory syndrome coronavirus 2
significantly lower
supplementary material
Surveillance
surveillance data
systemic reaction
systemic reactions
treatment groups
Vaccine
virus-like particle vaccine
was performed
Web of Science
[DOI] 10.1186/s12916-021-02059-5 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1186/s12916-021-02059-5 PMC 바로가기 [Article Type] Research Article